...
首页> 外文期刊>Journal of Transfusion >Anti-A and Anti-B Haemolysins amongst Group “O” Voluntary Blood Donors in Northeastern Nigeria
【24h】

Anti-A and Anti-B Haemolysins amongst Group “O” Voluntary Blood Donors in Northeastern Nigeria

机译:尼日利亚东北部的“O”自愿献血者抗A和抗B血换

获取原文
           

摘要

Background and Objective. The aim of this study was to determine the prevalence and haemolytic significance of alpha- and beta-haemolysins in our voluntary group “O” donor population. Methods. This was a prospective study carried out at North-East Zonal Centre, the National Blood Transfusion Service, Maiduguri, Nigeria from April 2007 to April 2009. One thousand nine hundred and twenty nine voluntary group “O” blood donors (1609 males and 320 females, median age 26 years ± 7.6 SD) were screened for alpha- (anti-A) and beta- (anti-B) haemolysins using the standard tube technique at 37 degrees C for 1 hour. All samples showing haemolysis were titrated for anti-A and anti-B haemolysins. Results. The overall prevalence of haemolysins in group O donors was 55.4%. Prevalence of alpha- and beta-haemolysins only was 10.3% and 12.6%, respectively, while that of donors having both alpha- and beta-haemolysins in their sera was 32.5%. Visual titre of 8 was seen in 0.4% of lytic alpha-haemolysin and 0.2% of lytic beta-haemolysin whereas donors with both alpha- and beta-haemolysins had a titre of 1.8%. Lytic titre of 16 and 32 was very low in our donor population. Conclusion. This study has shown that although the prevalence of haemolysins is high in our voluntary group “O” donor population, the strength of the lytic antibodies is low. Therefore, despite the labour intensiveness of our haemolysis titration technique and the frequent transfusion of group O blood to certain recipients of blood group A, B, and AB in our environments, there is the need to routinely screen our donors for haemolysins in order to identify those posing the greatest risk to recipients. Further studies to determine episodes of clinically significant haemolysis in recipients of blood group O may be necessary.
机译:背景和目标。本研究的目的是确定我们自愿组“o”捐助人群中α-β-氧蛋白酶的患病率和溶血性意义。方法。这是从2007年4月到2009年4月到2009年4月的东北地区中心,国家输血服务,尼日利亚国家输血服务,尼日利亚·米德古里,献血者(1609名男性和320名女性) ,使用标准管技术在37℃下筛选26岁26岁±7.6 sd)用于α-(抗A)和β-(抗-b)氧蛋白酶1小时。滴定显示溶血和抗B氧溶解的所有样品。结果。 o o捐助者溶血蛋白的总体患病率为55.4%。 α-β-溶血素的患病率分别为10.3%和12.6%,而血清中具有α-β-丙蛋白蛋白的供体的含量分别为32.5%。在0.4%的裂解α-氧蛋白和0.2%的Lytic Beta-haemolysin中看到的视觉滴度,而α-和β-氧溶胶的供体具有1.8%的滴度。在我们的捐助者人口中,Lytic Titre of 16和32的滴度非常低。结论。本研究表明,虽然我们自愿组“O”供体群中溶血素的患病率很高,但裂解抗体的强度低。因此,尽管我们的溶血性滴定技术和血液组A,B和AB的某些接受者的血液组A,B和AB的血液组,但需要常规筛选我们的溶血才能筛选出溶血性以便识别那些对收件人造成最大风险的人。进一步的研究,以确定血基o受者临床上显着的溶血的发作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号